Ultragenyx Pharmaceutical | Srodki Pieniężne I Ekwiwalent



Cash And Equivalent Zmiana Data
Acadia Pharmaceuticals USD 681.58M 74.42M 2025-03
Agios Pharmaceuticals USD 78.96M 2.72M 2025-03
Alnylam Pharmaceuticals USD 1.02B 53.23M 2025-03
BioMarin Pharmaceutical USD 612.03M 1.19M 2025-03
Insmed USD 403.25M 151.78M 2025-03
Ionis Pharmaceuticals USD 264.19M 22.12M 2025-03
Kyowa Hakko Kirin JPY 214.37B 30.31B 2025-03
MacroGenics USD 182.84M 3.22M 2024-12
Moderna USD 1.62B 304M 2025-03
Neurocrine Biosciences USD 233M 116.1M 2024-12
PTC Therapeutics USD 2.03B 1.25B 2025-03
Regeneron Pharmaceuticals USD 3.09B 14.82B 2025-03
Sarepta Therapeutics USD 240.87M 862.14M 2025-03
Ultragenyx Pharmaceutical USD 563M 389.27M 2025-03
Vertex Pharmaceuticals USD 4.57B 669.6M 2024-12



Ultragenyx Pharmaceutical Srodki Pieniężne I Ekwiwalent - Aktualne wartości, dane historyczne, prognozy, statystyki, wykresy i kalendarz ekonomiczny - May 2025.